Generic placeholder image

Current Gene Therapy

Editor-in-Chief

ISSN (Print): 1566-5232
ISSN (Online): 1875-5631

Review Article

Biogenesis and Function of circRNAs in Pulmonary Fibrosis

Author(s): Songzi Zhang, Wenjie Hu, Changjun Lv and Xiaodong Song*

Volume 24, Issue 5, 2024

Published on: 12 February, 2024

Page: [395 - 409] Pages: 15

DOI: 10.2174/0115665232284076240207073542

Price: $65

Abstract

Pulmonary fibrosis is a class of fibrosing interstitial lung diseases caused by many pathogenic factors inside and outside the lung, with unknown mechanisms and without effective treatment. Therefore, a comprehensive understanding of the molecular mechanism implicated in pulmonary fibrosis pathogenesis is urgently needed to develop new and effective measures. Although circRNAs have been widely acknowledged as new contributors to the occurrence and development of diseases, only a small number of circRNAs have been functionally characterized in pulmonary fibrosis. Here, we systematically review the biogenesis and functions of circRNAs and focus on how circRNAs participate in pulmonary fibrogenesis by influencing various cell fates. Meanwhile, we analyze the current exploration of circRNAs as a diagnostic biomarker, vaccine, and therapeutic target in pulmonary fibrosis and objectively discuss the challenges of circRNA- based therapy for pulmonary fibrosis. We hope that the review of the implication of circRNAs will provide new insights into the development circRNA-based approaches to treat pulmonary fibrosis.

Keywords: Pulmonary fibrosis, circRNA, biomarker, vaccine, circRNA-based therapy, biogenesis.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy